Jocelyn Ulrich serves as Vice President, Policy & Research at PhRMA, where she leads the organization's policy response to the Inflation Reduction Act. With over 20 years of experience, she is a senior pharmaceutical policy executive focused on shaping U.S.
federal legislation and regulatory strategy concerning drug pricing, intellectual property, and biopharmaceutical innovation. Her portfolio also spans domestic manufacturing, AI, and industry competitiveness.